Investments in private healthcare are not helping Africans | Canada News Media
Connect with us

Investment

Investments in private healthcare are not helping Africans

Published

 on

Recently, a good friend of mine took his perfectly healthy daughter to a private hospital in West Africa for a routine check-up. The paediatrician thought she was a bit thin for her age and advised that she undergo a surgical procedure, which is known to trigger weight gain in children. Despite the family’s misgivings, the operation went ahead.

She died on the operating table. It was a terrible loss. So many people I know in Africa have stories like this.

Public investment in essential public services has been in decline, creating a vacuum in healthcare provision that those seeking to make a profit are increasingly exploiting. But mixing profit maximisation with healthcare too often comes at an unacceptable cost.

Today, many private hospitals are abusing and violating the rights of patients and their relatives and impoverishing them. I see the devastating results every day in Africa – people faced with no choice but to watch their loved ones die, or forced to sell everything or take loans to pay the exorbitant medical bills.

However, the private sector continues to gain huge support as “the solution” to Africa’s development challenges.

Last month, I attended the Summit on the New Global Financial Pact in Paris on behalf of Oxfam. African leaders spoke passionately there about the issues affecting their citizens and, in particular, the need for public finance and public solutions. South Africa’s President Cyril Ramaphosa highlighted the profiteering by Big Pharma during the pandemic, and we kept saying, “What is more important, life or profits by your big pharmaceutical companies?”

But the World Bank and the rich countries instead again offered the private sector as the answer.

The new World Bank president, Ajay Banga, talked about how “for years, the World Bank Group, governments, and other multilateral institutions have tried – and fallen short – to mobilise meaningful private investment in emerging markets” and that “we must try a new approach … to catalyse private capital more effectively”.

In my view, the private sector knows quite well how to look after itself. It does not require taxpayers’ funding.

Sadly, and without asking us, governments in rich countries have contributed to this misery by underwriting and investing in these predatory private healthcare companies, feeding them to grow in our countries and become ever more powerful.

Oxfam recently released two shocking reports, based on complex and detailed investigative research in a number of countries.

We show how development institutions belonging to the governments of France, Germany, and the United Kingdom, as well as the European Union and the World Bank, are investing billions of dollars in Majority World countries into for-profit private hospital chains that block or bankrupt patients, deny them emergency medical care, with some even imprisoning patients and retaining corpses for non-payment of fees.

They are making huge profits for their already rich owners. All this, in the name of advancing universal health coverage and fighting poverty.

Ironically, the same rich countries provide healthcare and education funded by taxation and free of charge to their own citizens.

In Kenya, Oxfam unearthed dozens of cases of alleged or confirmed human rights violations by the Nairobi Women’s Hospital since 2017, including a newborn baby detained for three months, a schoolboy for 11 months, and a single mother of two for 226 days during which time her bill escalated by more than 2,000 percent.

The body of Francisca’s mother was locked in the hospital’s morgue for two years, she said. “I feel very sad seeing her … It is not easy for me because her body has changed … It does not look like a body any more, it’s more like a stone … We pleaded with the hospital to give us the body. We will never be able to pay the money, no matter how long they keep it.”

What upsets me most is that this hospital’s policy of detaining patients was already public knowledge before the rich countries chose to invest.

In Nigeria, nine out of 10 of the poorest women give birth with no medical care, yet childbirth at Development Finance Institution (DFI)-funded Evercare Hospital would cost those women their 12 years’ income.

Across all the hospitals getting these development funds, the average starting price for a childbirth procedure is more than a year’s income for an average earner in the poorest 40 percent.

During the COVID-19 pandemic, when people in my region of the world searched in desperation for scarce oxygen and life-saving care, exploitation escalated within some of these DFI-funded hospitals.

In Uganda, one of Africa’s poorest countries and hardest hit by the virus, private hospitals funded by European governments and the World Bank charged patient “clients” up to $2,300 per day for treatment and care. The Maputo Private Hospital reportedly charged COVID-19 patients an upfront deposit of more than $6,000 for oxygen and more than $10,000 for a ventilator.

In my view, the evidence is clear that the private sector is not the answer for the delivery of the public good. We know what the solution entails.

Instead of promoting the growth of expensive, out-of-reach hospitals for the elite, countries should support quality universal public services – funded by taxes and aid – and delivered free of charge at the point of use.

For example, look at the incredible improvements in healthcare delivered by thousands of new health workers in Ethiopia, pioneered by then minister of health, Dr Tedros Adhanom Ghebreyesus, before his time leading the World Health Organization.

European governments and the World Bank should stop funding for-profit private hospitals and evaluate the effect that their decades of investment in them have had on healthcare in Africa.

 

Source link

Continue Reading

Investment

Tesla shares soar more than 14% as Trump win is seen boosting Elon Musk’s electric vehicle company

Published

 on

 

NEW YORK (AP) — Shares of Tesla soared Wednesday as investors bet that the electric vehicle maker and its CEO Elon Musk will benefit from Donald Trump’s return to the White House.

Tesla stands to make significant gains under a Trump administration with the threat of diminished subsidies for alternative energy and electric vehicles doing the most harm to smaller competitors. Trump’s plans for extensive tariffs on Chinese imports make it less likely that Chinese EVs will be sold in bulk in the U.S. anytime soon.

“Tesla has the scale and scope that is unmatched,” said Wedbush analyst Dan Ives, in a note to investors. “This dynamic could give Musk and Tesla a clear competitive advantage in a non-EV subsidy environment, coupled by likely higher China tariffs that would continue to push away cheaper Chinese EV players.”

Tesla shares jumped 14.8% Wednesday while shares of rival electric vehicle makers tumbled. Nio, based in Shanghai, fell 5.3%. Shares of electric truck maker Rivian dropped 8.3% and Lucid Group fell 5.3%.

Tesla dominates sales of electric vehicles in the U.S, with 48.9% in market share through the middle of 2024, according to the U.S. Energy Information Administration.

Subsidies for clean energy are part of the Inflation Reduction Act, signed into law by President Joe Biden in 2022. It included tax credits for manufacturing, along with tax credits for consumers of electric vehicles.

Musk was one of Trump’s biggest donors, spending at least $119 million mobilizing Trump’s supporters to back the Republican nominee. He also pledged to give away $1 million a day to voters signing a petition for his political action committee.

In some ways, it has been a rocky year for Tesla, with sales and profit declining through the first half of the year. Profit did rise 17.3% in the third quarter.

The U.S. opened an investigation into the company’s “Full Self-Driving” system after reports of crashes in low-visibility conditions, including one that killed a pedestrian. The investigation covers roughly 2.4 million Teslas from the 2016 through 2024 model years.

And investors sent company shares tumbling last month after Tesla unveiled its long-awaited robotaxi at a Hollywood studio Thursday night, seeing not much progress at Tesla on autonomous vehicles while other companies have been making notable progress.

Tesla began selling the software, which is called “Full Self-Driving,” nine years ago. But there are doubts about its reliability.

The stock is now showing a 16.1% gain for the year after rising the past two days.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Investment

S&P/TSX composite up more than 100 points, U.S. stock markets mixed

Published

 on

 

TORONTO – Canada’s main stock index was up more than 100 points in late-morning trading, helped by strength in base metal and utility stocks, while U.S. stock markets were mixed.

The S&P/TSX composite index was up 103.40 points at 24,542.48.

In New York, the Dow Jones industrial average was up 192.31 points at 42,932.73. The S&P 500 index was up 7.14 points at 5,822.40, while the Nasdaq composite was down 9.03 points at 18,306.56.

The Canadian dollar traded for 72.61 cents US compared with 72.44 cents US on Tuesday.

The November crude oil contract was down 71 cents at US$69.87 per barrel and the November natural gas contract was down eight cents at US$2.42 per mmBTU.

The December gold contract was up US$7.20 at US$2,686.10 an ounce and the December copper contract was up a penny at US$4.35 a pound.

This report by The Canadian Press was first published Oct. 16, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX up more than 200 points, U.S. markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 200 points in late-morning trading, while U.S. stock markets were also headed higher.

The S&P/TSX composite index was up 205.86 points at 24,508.12.

In New York, the Dow Jones industrial average was up 336.62 points at 42,790.74. The S&P 500 index was up 34.19 points at 5,814.24, while the Nasdaq composite was up 60.27 points at 18.342.32.

The Canadian dollar traded for 72.61 cents US compared with 72.71 cents US on Thursday.

The November crude oil contract was down 15 cents at US$75.70 per barrel and the November natural gas contract was down two cents at US$2.65 per mmBTU.

The December gold contract was down US$29.60 at US$2,668.90 an ounce and the December copper contract was up four cents at US$4.47 a pound.

This report by The Canadian Press was first published Oct. 11, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version